Combination methods of treating cancer

Details for Australian Patent Application No. 2004270150 (hide)

International Classifications

Event Publications

23 March 2006 PCT application entered the National Phase

PCT publication WO2005/023179 Priority application(s): WO2005/023179

27 April 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Mar 2006

23 December 2010 Assignment before Grant

Aton Pharma, Inc.; Sloan-Kettering Institute for Cancer Research The application has been assigned to Merck HDAC Research, LLC; Sloan-Kettering Institute for Cancer Research

27 January 2011 Application Accepted

Published as AU-B-2004270150

24 March 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 03 Mar 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

14 July 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Mar 2011

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.